Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for Frontotemporal Dementia
NCT07638813Phase 2Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jul 2026
- Primary completion
- Oct 2027
01
Overview
A Phase 2 trial of umbilical cord derived mesenchymal stem cells exosomes in frontotemporal dementia (FTD), sponsored by Ruijin Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
umbilical cord derived mesenchymal stem cells exosomes
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT07638813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07638813.